PACIFIC LEGEND发布公告，于2025年11月18日(交易时段后)，公司与认购人订立认购协议，据此，公 司有条件同意配发及发行而认购人有条件同意认购合共1710万股认购股份，认购价为每股认购股份0.17 港元。 香港联交所最新资料显示，11月19日，PACIFIC LEGEND(08547)股东将股票由弘雅资本转入中国银行 (香港)，转仓市值623.48万港元，占比7.75%。 ...

Group 1 - The core viewpoint of the news is the signing of a memorandum of cooperation between China Merchants Fund, Smart (a subsidiary of the New Zealand Stock Exchange), and the New Zealand branch of the Bank of China, aimed at enhancing the connectivity and integration of the capital markets between China and New Zealand [1][2] - Smart, established in 1996, is the first ETF issuer in New Zealand, managing over 150 billion NZD in funds and offering 44 ETF products focused on various markets including New Zealand, Australia, the US, and global stocks [1] - The cooperation is expected to deepen understanding of the New Zealand market and its investors, and to develop cross-border investment products that meet the needs of investors from both countries, thereby enriching the international product system [1] Group 2 - Mark Peterson, CEO of the New Zealand Stock Exchange, emphasized that this year marks the beginning of the second decade of the comprehensive strategic partnership between China and New Zealand, highlighting the strong bilateral relationship [2] - The Bank of China has been a proactive promoter of financial cooperation between China and New Zealand, aiming to leverage its cross-border financial advantages to facilitate capital connectivity between the two countries [2] - The signing of the memorandum is seen as a significant milestone in deepening financial cooperation and a practical exploration of the integration of the capital markets between China and New Zealand, with plans to continuously improve the cross-border product system [2]

（原标题：PACIFIC LEGEND(08547)股东将股票由弘雅资本转入中国银行(香港) 转仓市值623.48万港 元） 智通财经APP获悉，香港联交所最新资料显示，11月19日，PACIFIC LEGEND(08547)股东将股票由弘雅 资本转入中国银行(香港)，转仓市值623.48万港元，占比7.75%。 PACIFIC LEGEND发布公告，于2025年11月18日(交易时段后)，公司与认购人订立认购协议，据此，公 司有条件同意配发及发行而认购人有条件同意认购合共1710万股认购股份，认购价为每股认购股份0.17 港元。 ...

Group 1 - The core point of the news is the signing of a memorandum of cooperation between China Merchants Fund, Smart (a subsidiary of the New Zealand Stock Exchange), and the Bank of China New Zealand branch, aimed at enhancing the connectivity and integration of the capital markets between China and New Zealand [2][5]. Group 2 - Smart, established in 1996 and fully owned by the New Zealand Stock Exchange, is the first ETF issuer in New Zealand, managing over NZD 15 billion in funds and offering 44 ETF products focused on various markets including New Zealand, Australia, the US, and global stocks [4]. - The cooperation is set against the backdrop of the updated Memorandum of Understanding on securities and futures regulatory cooperation signed between the China Securities Regulatory Commission and the New Zealand Financial Markets Authority on September 25, 2025, indicating a deepening regulatory collaboration [4]. - China Merchants Fund has 15 years of experience in ETF management, with a comprehensive product line covering currencies, bonds, A-shares, Hong Kong stocks, and cross-border investments, aiming to develop cross-border investment products that meet the needs of investors from both countries [4]. Group 3 - Mark Peterson, CEO of the New Zealand Stock Exchange, emphasized that this year marks the beginning of the second decade of the comprehensive strategic partnership between China and New Zealand, highlighting the strong bilateral relationship and the potential benefits for investors from both countries through this collaboration [5]. - The Bank of China has been a proactive promoter of financial cooperation between China and New Zealand, supporting the project and aiming to deepen practical cooperation and accelerate product innovation for mutual market opportunities [5]. - The signing of the memorandum is seen as a significant milestone in deepening financial cooperation among the three parties and a practical exploration of the integration of the capital markets between China and New Zealand [5].

Core Viewpoint - The signing of the memorandum of cooperation between China Merchants Fund, Smart, and Bank of China New Zealand marks a significant step towards enhancing the connectivity and integration of the capital markets between China and New Zealand, aiming to develop cross-border investment products that meet the needs of investors from both countries [1][3][4]. Group 1: Partnership Details - The cooperation memorandum was signed on November 19, 2025, in Beijing, with the involvement of the New Zealand Stock Exchange and Bank of China [1]. - Smart, established in 1996 and fully owned by the New Zealand Stock Exchange, manages over NZD 15 billion in funds and offers 44 ETF products focused on various markets including New Zealand, Australia, the US, and global stocks [3]. - The partnership aims to leverage the experience of China Merchants Fund in ETF management, which spans 15 years, to better understand the New Zealand market and develop suitable cross-border investment products [3]. Group 2: Strategic Importance - The year 2025 marks the beginning of the second decade of the comprehensive strategic partnership between China and New Zealand, with China being New Zealand's largest trading partner [4]. - The collaboration is seen as a vital link in enhancing the relationship between the capital markets and asset management industries of both countries, with expectations for mutual benefits for investors [4]. - Bank of China emphasizes its role as a facilitator of cross-border financial cooperation, supporting the project and aiming to accelerate product innovation for shared market opportunities [4].

Group 1: Central Bank Operations - The central bank conducted a 310.5 billion yuan 7-day reverse repurchase operation, with a bid amount and winning amount of 310.5 billion yuan, maintaining an operation rate of 1.40% [1] Group 2: Banking Sector Performance - A-shares in the banking sector experienced fluctuations but generally rose, with China Bank's stock price increasing over 2% to reach a new high, alongside significant gains from other banks such as Everbright Bank and CITIC Bank [2] - The rise in bank stock prices reflects positive market expectations for future growth in the financial industry, likely driven by economic recovery expectations and policy support [2] Group 3: Insurance Sector Performance - The insurance sector in A-shares continued to rise, with China Life and China Property & Casualty Insurance both increasing over 3%, along with other major insurers [3] - The notable growth in the insurance sector indicates investor optimism, potentially influenced by market perceptions of economic stability and increased risk management awareness among individuals [3] Group 4: Gold Market Trends - Spot gold prices reached 4,100 USD per ounce, reflecting a 0.85% increase during the day [4] - The rise in gold prices indicates a sustained preference for safe-haven assets, driven by increasing geopolitical risks and inflation pressures, showcasing gold's appeal as a traditional safe-haven investment [4]

Market Overview - The Hang Seng Index (HSI) closed at 25,824.00, down by 6.65 points or 0.03% as of November 19, 16:00 Eastern Time [1] - The index's highest price during the day was 25,935.21, while the lowest was 25,751.31, with a trading volume of 43.34 million shares [1] Major Blue-Chip Stocks Performance - HSBC Holdings closed at HKD 107.800, down by HKD 1.800 or 1.64% compared to the previous close [2][3] - Tencent Holdings closed at HKD 622.500, down by HKD 1.000 or 0.16% [3] - Alibaba Group (ADR) saw an increase, closing at HKD 156.400, up by HKD 1.800 or 1.16% [3] - Xiaomi Group closed at HKD 38.820, down by HKD 1.960 or 4.81% [3] - AIA Group closed at HKD 77.950, down by HKD 0.600 or 0.76% [3] Stock Price Changes - The stock prices of major companies showed mixed results, with some experiencing declines while others saw slight increases [2][3] - Notable declines included Kuaishou Technology, which closed at HKD 63.500, down by HKD 1.150 or 1.78% [3] - Ctrip Group saw an increase, closing at HKD 574.500, up by HKD 10.000 or 1.77% [3]

Core Viewpoint - Sichuan Baile Tianheng Pharmaceutical Co., Ltd. has signed a strategic cooperation agreement with Bank of China Sichuan Branch to establish a long-term comprehensive strategic partnership, which aims to support the company's development in the innovative drug research and industrialization process [2][10]. Group 1: Agreement Details - The strategic cooperation agreement involves a commitment from Bank of China Sichuan Branch to provide a total of no less than 8 billion RMB in comprehensive credit support to the company [8]. - The agreement will facilitate deep cooperation in areas such as capital market operations, cross-border finance, and innovative financial services [9]. - The agreement is effective for five years and will automatically renew unless otherwise agreed upon by both parties [10]. Group 2: Impact on the Company - The signing of this strategic cooperation agreement is expected to accelerate the company's strategic layout in the global biopharmaceutical frontier, particularly in the fields of antibody-drug conjugates (ADC) and multi-specific antibodies [10]. - This partnership is anticipated to provide significant financial support for the company's future development, aligning with the company's development plan and benefiting all shareholders [10].

Core Insights - The "2025 China Banking Industry Tianji Award" results were announced during the "19th Shenzhen International Financial Expo and 2025 China Financial Institutions Annual Conference" held on November 19-20 [2][3] - The conference theme was "Empowering through Synergy, Reshaping Value," featuring discussions on current hot topics in China's economy and finance by over 1,000 industry elites from leading banks, insurance companies, securities firms, and futures companies [1] Group 1 - The "Tianji Award" is a prestigious industry award organized by the Securities Times, focusing on the progress and development of commercial banks over the past year [3] - The award has been held for seven consecutive years, with nearly 100 participating institutions each year, making it one of the most professional and influential brand events in the domestic banking sector [3] - The evaluation process of the "Tianji Award" adheres to principles of fairness, openness, and impartiality, utilizing a combination of quantitative indicators, expert reviews, and WeChat voting to identify the best companies, valuable innovations, and meaningful practices in the Chinese banking industry [3]

Core Viewpoint - The company, Baillie Gifford Tianheng (688506.SH), has signed a strategic cooperation agreement with the Bank of China Sichuan Branch to establish a long-term comprehensive strategic partnership, which includes a commitment to provide no less than 8 billion yuan in credit support for the company's development strategy [1] Group 1: Strategic Cooperation - The agreement involves specific business operations that will require separate contracts to be signed [1] - The Bank of China has acknowledged the funding needs faced by the company in the process of innovative drug research and industrialization [1] Group 2: Financial Support - The strategic cooperation is expected to accelerate the company's strategic layout in the global biopharmaceutical frontier, reinforcing its leading position in fields such as antibody-drug conjugates (ADC) and multi-specific antibodies [1] - This partnership aims to seize new opportunities in the global biopharmaceutical industry, promoting mutual benefits and joint development [1]